76 related articles for article (PubMed ID: 20946916)
1. Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues.
Ramos-Medina R; Montes-Moreno S; Maestre L; Cañamero M; Rodriguez-Pinilla M; Lázaro A; Roncador G
Immunol Lett; 2011 Jan; 134(2):150-6. PubMed ID: 20946916
[TBL] [Abstract][Full Text] [Related]
2. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
3. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
[TBL] [Abstract][Full Text] [Related]
4. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
Cartun RW; Coles FB; Pastuszak WT
Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
[TBL] [Abstract][Full Text] [Related]
5. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
[TBL] [Abstract][Full Text] [Related]
6. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Mackay CR; Dorfman DM
Hum Pathol; 2005 Oct; 36(10):1113-9. PubMed ID: 16226112
[TBL] [Abstract][Full Text] [Related]
7. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
8. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
9. Production of two monoclonal antibodies (FB1 and FB21) useful for the identification of human B lymphocytes in formalin-fixed, paraffin-embedded tissues.
Nozawa Y; Abe M; Ohno H; Fukuhara S; Wakasa H
J Pathol; 1994 Aug; 173(4):347-54. PubMed ID: 7965394
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of novel cell surface molecules on B-cell subsets and plasma cells as analyzed by flow cytometry.
Llinàs L; Lázaro A; de Salort J; Matesanz-Isabel J; Sintes J; Engel P
Immunol Lett; 2011 Jan; 134(2):113-21. PubMed ID: 20951740
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
12. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
14. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
[TBL] [Abstract][Full Text] [Related]
15. HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.
Bijl JJ; Rieger E; van Oostveen JW; Walboomers JM; Kreike M; Willemze R; Meijer CJ
Am J Pathol; 1997 Oct; 151(4):1067-74. PubMed ID: 9327740
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
Marder RJ; Variakojis D; Silver J; Epstein AL
Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.
Poppema S; Hollema H; Visser L; Vos H
Am J Pathol; 1987 Jun; 127(3):418-29. PubMed ID: 3296769
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
19. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody.
Nakamura N; Hase H; Sakurai D; Yoshida S; Abe M; Tsukada N; Takizawa J; Aoki S; Kojima M; Nakamura S; Kobata T
Virchows Arch; 2005 Jul; 447(1):53-60. PubMed ID: 16025281
[TBL] [Abstract][Full Text] [Related]
20. Two new monoclonal antibodies, EPB-1 and EPB-2, reactive with human lymphoma.
Pawlak-Byczkowska EJ; Hansen HJ; Dion AS; Goldenberg DM
Cancer Res; 1989 Aug; 49(16):4568-77. PubMed ID: 2663143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
